Impact of misclassification in genotype-exposure interaction studies: Example of N-acetyltransferase 2 (NAT2), smoking, and bladder cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 9, 2004, Pages 1543-1546

  Deitz, Anne C ^a   Rothman, Nathanial ^b   Rebbeck, Timothy R ^a   Hayes, Richard B ^b   Chow, Wong Ho ^b   Zheng, Wei ^c   Hein, David W ^d   García Closas, Montserrat ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE;

ACETYLATION; ARTICLE; BLADDER CANCER; CANCER RISK; CONTROLLED STUDY; FEMALE; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

ALLELES; ARYLAMINE N-ACETYLTRANSFERASE; BIAS (EPIDEMIOLOGY); BREAST NEOPLASMS; CARCINOGENS; CASE-CONTROL STUDIES; COCARCINOGENESIS; COHORT STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MODELS, GENETIC; MODELS, STATISTICAL; ODDS RATIO; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RISK ASSESSMENT; SAMPLE SIZE; SMOKING; STOMACH NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 4444258254     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Cascorbi I, Brockmoller J, Mrozikiewicz PM, Muller A, Roots I. Arylamine N-acetyltransferase activity in man. Drug Metab Rev 1999;31:489-502.
2. Gross M, Kruisselbrink T, Anderson K, et al. Distribution and concordance of N-acetyltransferase genotype and phenotype in an American population. Cancer Epidemiol Biomarkers Prev 1999;8:683-92.
3. Rothman N, Stewart WF, Caporaso NE, Hayes RB. Misclassification of genetic susceptibility biomarkers; implications for case-control studies and cross-population comparisons. Cancer Epidemiol Biomarkers Prev 1993;2:299-303.
4. Bell DA, Taylor JA, Butler MA, et al. Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis 1993;14:1689-92.
5. Garcia-Closas M, Rothman N, Lubin J. Misclassification in case-control studies of gene-environment interactions: assessment of bias and sample size. Cancer Epidemiol Biomarkers Prev 1999;8:1043-50.
6. Lan Q, Rothman N, Chow WH, et al. No apparent association between NAT1 and NAT2 genotypes and risk of stomach cancer. Cancer Epidemiol Biomarkers Prev 2003;12:384-6.
7. Deitz AC, Zheng W, Leff MA, et al. N-acetyltransferase-2 generic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women. Cancer Epidemiol Biomarkers Prev 2000;9:905-10.
8. Hein DW, Doll MA, Fretland AJ, et al. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev 2000;9:29-42.
9. Fretland AJ, Leff MA, Doll MA, Hein DW. Functional characterization of human N-acetyltransferase 2 (NAT2) single nucleotide polymorphisms. Pharmacogenetics 2001;11:207-15.
10. Le Marchand L, Hankin JH, Wilkens LR, et al. Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:1259-66.
11. Marcus PM, Hayes RB, Vineis P, et al. Cigarette smoking, N-aceryltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. Cancer Epidemiol Biomarkers Prev 2000;9:461-7.
12. Flegal KM, Brownie C, Haas JD. The effects of exposure misclassification on estimates of relative risk. Am J Epidemiol 1986;123:736-50.
13. Doll MA, Hein DW. Comprehensive human NAT2 genotype method using single nucleotide polymorphism-specific polymerase chain reaction primers and fluorogenic probes. Anal Biochem 2001;288:106-8.